Impacts of Dietary Protein and Prebiotic Inclusion on Liver and Spleen Gene Expression in Hy-Line Brown Caged Layers.
Morouj N Al-AjeeliShawna Marie HubertHector Leyva-JimenezMohammed M HashimRaghad A AbdaljaleelAkhil M AlsadwiGiridhar N AthreyChristopher A BaileyPublished in: Animals : an open access journal from MDPI (2020)
The ingredients of poultry feeds are chosen based on the least-cost formulation to meet nutritional requirements. However, this approach can lead to the introduction of anti-nutritional ingredients in the feed. The objective of this study was to evaluate the impacts of two diets (with or without prebiotic) on homeostatic genes in the liver and spleen of laying hens. Hy-Line Brown layers were raised either on a soybean meal or cottonseed meal-based diets with and without an added prebiotic (yeast cell wall), totaling four experimental diets. A total of 120, 63-week old layers were housed individually in a wire cage system. We investigated differences in the expression of select homeostatic marker genes in the liver and spleen of hens from each treatment. We then used the ΔΔCT and generalized linear models to assess significance. Results show that the inclusion of prebiotic yeast cell-wall (YCW) increased the expression of the BAK gene in the liver tissue for both the soybean meal (SBM) and cottonseed meal (CSM) diets. For splenic tissue, the combination of YCW with the CSM diet increased the POR gene over six log2 fold. Altogether, our results suggest altered homeostasis, which can have consequences for health and performance.
Keyphrases
- cell wall
- weight loss
- genome wide
- gene expression
- genome wide identification
- poor prognosis
- heat stress
- dna methylation
- healthcare
- computed tomography
- public health
- copy number
- binding protein
- physical activity
- mental health
- genome wide analysis
- high resolution
- drug delivery
- magnetic resonance
- climate change
- bioinformatics analysis
- saccharomyces cerevisiae
- social media
- smoking cessation
- combination therapy
- type iii
- replacement therapy
- atomic force microscopy
- risk assessment
- dual energy